Stuart C. Sealfon, MD, Named Chair of Neurology at Mount Sinai School of Medicine

Stuart C. Sealfon, MD, a leader in the study of the mechanisms of therapeutic and side effects of drugs, has been named Chair of the Department of Neurology.

New York, NY
 – May 6, 2009 /Press Release/  –– 

Stuart C. Sealfon, MD, a leader in the study of the mechanisms of therapeutic and side effects of drugs, has been named Chair of the Department of Neurology. His appointment becomes effective on June 1.

Dr. Sealfon, who had been Vice Chairman for Research in the Department of Neurology and Saunders Family Professor of Neurology, Neurobiology, Pharmacology and Systems Therapeutics, has either directed or co-directed several research and education programs and initiatives at Mount Sinai including: the Pharmacology and Systems Biology Graduate Student Multidisciplinary Training Area; the Center for Genomics, Proteomics and Bioinformatics; and the Center for Translational Systems Biology. Dr. Sealfon also leads the Modeling Immunity for Biodefense Center/Program for Research on Immune Modeling and Experimentation (PRIME).

Dr. Sealfon is one of our nation’s outstanding systems biologists. I am confident he will provide inspiring leadership to Mount Sinai’s Department of Neurology, said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of Mount Sinai School of Medicine and Executive Vice President for Academic Affairs at The Mount Sinai Medical Center.

At Mount Sinai, Dr. Sealfon’s laboratory applies a diverse systems biology approach to better understand how cells recognize and generate responses to extracellular signals or stimuli. His research focuses on signaling systems which are critical for understanding cell responses related to a broad range of neurological conditions.

Dr. Sealfon received his A.B. at Princeton University. After earning his medical degree from Columbia University College of Physicians and Surgeons, Dr. Sealfon completed his residency training in neurology at Massachusetts General Hospital. He has been associated with Mount Sinai for more than two decades, as he first joined Mount Sinai as fellow in Neuroscience in 1986. Dr. Sealfon holds board certification in Neurology.

Dr. Sealfon has contributed to more than 100 original research articles, primarily related to receptors, cell signaling and brain disease. This body of work has significant potential for therapeutic advance, already having led to two awarded patents. He has also served on the editorial boards of numerous peer-reviewed journals and scientific advisory boards, and has lectured at universities and conferences throughout the world.

About The Mount Sinai Medical Center The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation’s oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 50,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center.

Mount Sinai School of Medicine is internationally recognized as a leader in groundbreaking clinical and basic science research, as well as having an innovative approach to medical education. With a faculty of more than 3,400 in 38 clinical and basic science departments and centers, Mount Sinai ranks among the top 20 medical schools in receipt of National Institute of Health (NIH) grants.

About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation’s oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 50,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center.

Mount Sinai School of Medicine is internationally recognized as a leader in groundbreaking clinical and basic-science research, as well as having an innovative approach to medical education. With a faculty of more than 3,400 in 38 clinical and basic science departments and centers, Mount Sinai ranks among the top 20 medical schools in receipt of National Institute of Health (NIH) grants.